*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. In re Flonase Antitrust Litigation: United States District Court for the Eastern District of Pennsylvania, Case no. 2:08-CV-3301, June 2, 2011, "GlaxoSmithKline" On June 2, 2011, the U.S. District Court for the Eastern District of Pennsylvania
CASE COMMENTS: NATIONAL CASE LAW – ANTITRUST – UNITED STATES – MOTION TO DISMISS – TACTICS TO DELAY THE APPROVAL OF GENERICS
Antitrust – United States – Tactics to delay the approval of generics: A Federal Court refuses to dismiss an antitrust case against a pharmaceutical company (GlaxoSmithKline)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.